Gritstone Bio Inc (NASDAQ: GRTS) kicked off on Monday, down -6.25% from the previous trading day, before settling in for the closing price of $0.56. Over the past 52 weeks, GRTS has traded in a range of $0.52-$3.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 230.33%. While this was happening, its average annual earnings per share was recorded 11.87%. With a float of $99.64 million, this company’s outstanding shares have now reached $108.57 million.
Considering the fact that the conglomerate employs 231 people, you should pay attention to its efficiency factor.
Gritstone Bio Inc (GRTS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gritstone Bio Inc is 8.23%, while institutional ownership is 38.53%. The most recent insider transaction that took place on May 16 ’24, was worth 18,156. In this transaction PRESIDENT AND CEO of this company sold 24,263 shares at a rate of $0.75, taking the stock ownership to the 985,360 shares. Before that another transaction happened on May 16 ’24, when Company’s EVP, CHIEF OPERATING OFFICER sold 13,749 for $0.75, making the entire transaction worth $10,288. This insider now owns 359,293 shares in total.
Gritstone Bio Inc (GRTS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 11.87% per share during the next fiscal year.
Gritstone Bio Inc (NASDAQ: GRTS) Trading Performance Indicators
Take a look at Gritstone Bio Inc’s (GRTS) current performance indicators. Last quarter, stock had a quick ratio of 1.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 67.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.30, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.97 in one year’s time.
Technical Analysis of Gritstone Bio Inc (GRTS)
Compared to the last year’s volume of 2.29 million, its volume of 1.19 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.32%. Additionally, its Average True Range was 0.06.
During the past 100 days, Gritstone Bio Inc’s (GRTS) raw stochastic average was set at 0.62%, which indicates a significant decrease from 6.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.89% in the past 14 days, which was lower than the 134.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6897, while its 200-day Moving Average is $1.5201. Nevertheless, the first resistance level for the watch stands at $0.5466 in the near term. At $0.5682, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5865. If the price goes on to break the first support level at $0.5067, it is likely to go to the next support level at $0.4884. Should the price break the second support level, the third support level stands at $0.4668.
Gritstone Bio Inc (NASDAQ: GRTS) Key Stats
The company with the Market Capitalisation of 57.00 million has total of 108,569K Shares Outstanding. Its annual sales at the moment are 16,340 K in contrast with the sum of -138,490 K annual income. Company’s last quarter sales were recorded 1,740 K and last quarter income was -40,390 K.
